Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
2
×
life sciences
national blog main
software
2
×
agios pharmaceuticals
ally bridge group
big data analytics
blackrock
boston
cancer
cancer drugs
casdin capital
david e. shaw
diabetic nephropathy
drug discovery
enasidenib
eventide asset management
fda
focal segmental glomerulosclerosis
goldfinch bio
investing
ipo
irving investors
ivosidenib
jay ghosh
materials science
morphic
national top stories
new york
new york blog main
new york top stories
nimbus therapeutics
sanofi
schroeder adveq
schrödinger
takeda pharmaceutical
the bill & melinda gates foundation trust
What
ipo
2
×
medicines
analysis
bio
biotech
bring
company
company’s
course
develop
development
discover
diseases
drug
employing
experimental
genetic
goldfinch
growing
handiwork
helped
internal
kidney
landscape
later
lead
million
new
pipeline
raised
raises
scan
schrödinger
schrödinger’s
sets
software
spot
studies
support
today
Language
unset
2
×
Current search:
software
×
unset
×
" clinical trials "
×
ipo
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline